연구동향 분석

전신성 홍반성 루푸스의 병인으로서의 뉴로필린-1의 역할 및 임상적 의의 = Pathogenic roles and clinical value of Neuropilin-1 in systemic lupus erythematosus

이은경 2022년

논문상세정보
인용/피인용
' 전신성 홍반성 루푸스의 병인으로서의 뉴로필린-1의 역할 및 임상적 의의 = Pathogenic roles and clinical value of Neuropilin-1 in systemic lupus erythematosus' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Disease activity
  • Lupus murine model
  • NRP-1
  • Neuropilin-1
  • dendritic cell
  • sle
  • systemic lupus erythematosus
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
117 0

0.0%

' 전신성 홍반성 루푸스의 병인으로서의 뉴로필린-1의 역할 및 임상적 의의 = Pathogenic roles and clinical value of Neuropilin-1 in systemic lupus erythematosus' 의 참고문헌

  • VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors .
    Grun D , Adhikary G , Eckert RL . 35 ( 33 ) :4379-87 . [2016]
  • The role of semaphorins in immune responses and autoimmune rheumatic diseases
    Nishide M , Kumanogoh A . 14 ( 1 ) :19-31 . [2018]
  • The regulatory mechanism and biological significance of the Snail-miR590-VEGFR-NRP1 axis in the angiogenesis , growth and metastasis of gastric cancer
  • The involvement of immune semaphorins and neuropilin-1 in lupus nephritis .
  • Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice
  • Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development .
  • TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
  • Systemic lupus erythematosus : all roads lead to type I interferons
    Pascual V , Farkas L , Banchereau J . 18 ( 6 ) :676-82 . [2006]
  • Structural and functional relation of neuropilins
    Nakamura F , Goshima Y 515:55-69 [2002]
  • Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A ( VEGF-A ) interaction
  • Regulation of T cell expansion by antigen presentation dynamics
  • Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease
    Rahat MA , Shakya J 2016:4375120 [2016]
  • Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
  • Nrp1 , a Neuronal Regulator , Enhances DDR2-ERK-Runx2 Cascade in Osteoblast Differentiation via Suppression of DDR2 Degradation .
  • Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages
    Kang JY , Gil M , Kim KE 9 ( 5 ) :1430 [2020]
  • Neuropilin-1 expression in adipose tissue macrophages protects against obesity and metabolic syndrome
  • Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer
  • Neuropilin-1 as Therapeutic Target for Malignant Melanoma
  • NF-κB Signaling in Macrophages : Dynamics , Crosstalk , and Signal Integration
  • NF-kappaB : a stress-regulated switch for cell survival .
    Piva R , Belardo G , Santoro MG. 8 ( 3-4 ) :478-86 . [2006]
  • MAPK signal pathways in the regulation of cell proliferation in mammalian cells
    Zhang , W. , & Liu , H. T. 12 ( 1 ) :9-18 . [2002]
  • Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus
  • Genetic status of KRAS influences Transforming Growth Factor-beta ( TGF-β ) signaling : An insight into Neuropilin-1 ( NRP1 ) mediated tumorigenesis
  • Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
  • Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models
  • Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice : a new model of systemic Lupus erythematosus
  • Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
    Sallusto F , Lanzavecchia A . 179 ( 4 ) :1109-18 . [1994]
  • Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus .
  • Dendritic cells as key players in systemic lupus erythematosus
  • Dendritic Cells in Systemic Lupus Erythematosus : From Pathogenic Players to Therapeutic Tools
  • Deletion of Neuropilin 1 from Microglia or Bone Marrow-Derived Macrophages Slows Glioma Progression
  • Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma
    Zhang GP , Yue X , Li SQ . ; 52 ( 1 ) :10-23 . [2020]
  • CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome
  • A neuronal receptor , neuropilin-1 , is essential for the initiation of the primary immune response
  • 9. Chaudhary B, Khaled YS, Ammori BJ, Elkord E. Neuropilin 1: function and therapeutic potential in cancer. Cancer Immunol Immunother. 2014;63(2):81-99.
    [2014]
  • 8. Fujisawa H, Takagi S, Hirata T. Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers. Dev Neurosci. 1995;17(5-6):343-9.
    [1995]
  • 55. Kleiveland CR. Peripheral Blood Mononuclear Cells. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, et al., editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models. Cham (CH): Springer Copyright 2015, The Author(s). 2015.161-7.
  • 54. Yoshimura S, Bondeson J, Foxwell BM, Brennan FM, Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol. 2001;13(5):675-83.
    [2001]
  • 50. Li Y, Luo JT, Liu YM, Wei WB. miRNA-145/miRNA-205 inhibits proliferation and invasion of uveal melanoma cells by targeting NPR1/CDC42. Int J Ophthalmol. 2020;13(5):718-24.
    [2020]
  • 49. Jimenez-Hernandez LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, Muñoz-Galindo L, Gonzalez-Torres C, et al. NRP1-positive lung cancer cells possess tumor-initiating properties. Oncol Rep. 2018;39(1):349-57.
    [2018]
  • 47. Torres-Salido MT, Sanchis M, Solé C, Moliné T, Vidal M, Vidal X, et al. Urinary Neuropilin-1: A Predictive Biomarker for Renal Outcome in Lupus Nephritis. Int J Mol Sci. 2019;20(18):4601.
    [2019]
  • 43. Dong Y, Ma WM, Shi ZD, Zhang ZG, Zhou JH, Li Y, et al. Role of NRP1 in Bladder Cancer Pathogenesis and Progression. Front Oncol. 2021;11:685980.
  • 4. Gottenberg JE, Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie. 2007;89(6-7):856-71.
    [2007]
  • 38. Raimondi C, Brash JT, Fantin A, Ruhrberg C. NRP1 function and targeting in neurovascular development and eye disease. Prog Retin Eye Res. 2016;52:64-83.
    [2016]
  • 33. Jia H, Bagherzadeh A, Hartzoulakis B, Jarvis A, Löhr M, Shaikh S, et al. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem. 2006;281(19):13493-502.
    [2006]
  • 32. Choi Y, Jung JH, Lee EG, Kim KM, Yoo WH. 4-phenylbutyric acid mediates therapeutic effect in systemic lupus erythematosus: Observations in an experimental murine lupus model. Exp Ther Med. 2021;21(5):460.
  • 31. Hanata N, Shoda H, Hatano H, Nagafuchi Y, Komai T, Okamura T, et al. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice. Front Immunol. 2020;11:1095.
  • 27. Yan JJ, Lee JG, Jang JY, Koo TY, Ahn C, Yang J. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4(+)CD25(+)Foxp3(+) regulatory T cells. Kidney Int. 2017;91(3):603-15.
    [2017]
  • 20. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288-91.
    [2002]
  • 2. Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019;96:1-13.
    [2019]
  • 19. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-86.
    [2012]
  • 18. Campos-Mora M, Morales RA, Gajardo T, Catalán D, Pino-Lagos K. Neuropilin-1 in transplantation tolerance. Front Immunol. 2013;4:405.
    [2013]
  • 16. Romeo PH, Lemarchandel V, Tordjman R. Neuropilin-1 in the immune system. Adv Exp Med Biol. 2002;515:49-54.
    [2002]
  • 15. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165(11):6037-46.
    [2000]
  • 10. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997;90(4):739-51.
    [1997]
  • 1. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878-88.
    [2014]